This drug test will test for:

  • ALL OPIATES (including Heroin, Morphine, Codeine and Oxycodone)    
  • COCAINE (including Crack and Coke)
  • ‘SPEED’ (including Whizz and all Amphetamines)
  • MDMA (Ecstasy or E's, Methylenedioxymethylamphetamine, plus MDA and MDE)
  • CANNABIS (including Cannabis resin, Skunk and Herbal)
  • BENZODIAZEPENES (including ‘Valium’, Rohypnol, diazepam etc.)


This is a rapid, one step screening test for the simultaneous, qualitative detection of multiple drugs and drug metabolites in human urine.

Simple, Accurate and Reliable
All tests are CE Marked with an accuracy level of 99%
Easy to follow instructions

Every pack has the approval details and the expiry date printed on them. The current batch of tests expires 02/2018.

DIRECTIONS FOR USE: (Instructions included)

  1. Open the sealed pouch by tearing along the notch. Remove the test device from its protective pouch 
  2. Label the device with patient or control number if needed.
  3. Hold the test kit in the urine sample for 10-15 seconds. Withdraw the test kit from the sample and lay it down on a clean surface.
  4. Read result at 5 minutes after the addition of samples. 



Drug Test is "positive" if the "C" line appears.

Drug Test is "negative" if both "C" and "T" lines appear.

Drug Test is "invalid" if the "C" line does not appear




This test kit is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of specific drugs in urine.



Methylenedioxymethamphetamine (ecstasy) is a designer drug first synthesized in 1914 by a German drug company for the treatment of obesity. Those who take the drug frequently report adverse effects, such as increased muscle tension and sweating. MDMA is not clearly a stimulant, although it has, in common with amphetamine drugs, a capacity to increase blood pressure and heart rate. MDMA does produce some perceptual changes in the form of increased sensitivity to light, difficulty in focusing, and blurred vision in some users. Its mechanism of action is thought to be via release of the neurotransmitter serotonin. MDMA may also release dopamine, although the general opinion is that this is a secondary effect of the drug (Nichols and Oberlender, 1990). The most pervasive effect of MDMA, occurring in virtually all people who took a reasonable dose of the drug, was to produce a clenching of the jaws. This test yields a positive result when the MDMA in urine exceeds 500ng/ml.



Opiate refers to any drug that is derived from the opiate poppy, including the natural products, morphine and codeine, and the semi-synthetic drugs such as heroin. Opioid is more general, referring to any drug that acts on the opioid receptor. Opioid analgesics comprise a large group of substances which control pain by depressing the central nervous system. Large doses of morphine can produce higher tolerance levels, physiological dependency in users, and may lead to substance abuse. Morphine is excreted unmetabolised, and is also the major metabolic product of codeine and heroin. Morphine is detectable in the urine for several days after an opiate dose. This test yields a positive result when the concentration of morphine in urine exceeds 300ng/ml.



Cocaine is a potent central nervous system (CNS) stimulant and a local anesthetic. Initially, it brings about extreme energy and restlessness while gradually resulting in tremors, over-sensitivity and spasms. In large amounts, cocaine causes fever, unresponsiveness, and difficulty in breathing and unconsciousness. Cocaine is often self-administered by nasal inhalation, intravenous injection and free-base smoking. It is excreted in the urine in a short time primarily as Benzoylecgonine1,2. Benzoylecgonine, a major metabolite of cocaine, has a longer biological half-life (5-8 hours) than cocaine (0.5-1.5 hours), and can generally be detected for 24-48 hours after cocaine exposure. This test yields a positive result when the concentration of cocaine metabolite in urine exceeds 300 ng/ml. This is the suggested screening cut-off for positive specimens set by the Substance Abuse and Mental Health Services Administration (SAMHSA, USA).



Amphetamine is a Schedule II controlled substance available by prescription (Dexedrine®) and is also available on the illicit market. Amphetamines are a class of potent sympathomimetic agents with therapeutic applications. They are chemically related to the human body’s natural catecholamines: epinephrine and norepinephrine. Acute higher doses lead to enhanced stimulation of the central nervous system and induce euphoria, alertness, reduced appetite, and a sense of increased energy and power. Cardiovascular responses to Amphetamines include increased blood pressure and cardiac arrhythmias. More acute responses produce anxiety, paranoia, hallucinations, and psychotic behaviour. The effects of Amphetamines generally last 2-4 hours following use, and the drug has a half-life of 4-24 hours in the body. About 30% of Amphetamines are excreted in the urine in unchanged form, with the remainder as hydroxylated and deaminated derivatives. This test yields a positive result when the concentration of amphetamine in urine exceeds 1,000ng/ml.



THC (^9-tetrahydrocannabinol) is the primary active ingredient in cannabinoids (marijuana). When smoked or orally administered, it produces euphoric effects. Users have impaired short term memory and slowed learning. They may also experience transient episodes of confusion and anxiety. Long term relatively heavy use may be associated with behavioral disorders. The peak effect of smoking marijuana occurs in 20-30 minutes and the duration is 90-120 minutes after one cigarette. Elevated levels of urinary metabolites are found within hours of exposure and remain detectable for 3-10 days after smoking. The main metabolite excreted in the urine is 11-nor-^9-tetrahydrocannabinol-9-carboxylic acid (^9-THC-COOH). This test yields a positive result when the concentration of marijuana in urine exceeds 50ng/ml. This is the suggested screening cut-off for positive specimens set by the Substance Abuse and Mental Health Services Administration (SAMHSA, USA). 


Barbiturates are central nervous system depressants. They are used therapeutically as sedatives, hypnotics, and anticonvulsants. Barbiturates are almost always taken orally as capsules or tablets. The effects resemble those of intoxication with alcohol. Chronic use of barbiturates leads to tolerance and physical dependence. Short acting Barbiturates taken at 400 mg/day for 2-3 months produces a clinically significant degree of physical dependence. Withdrawal symptoms experienced during periods of drug abstinence can be severe enough to cause death. Only a small amount (less than 5%) of most Barbiturates are excreted unaltered in the urine. This test yields a positive result when the Barbiturates in urine exceeds 300 ng/ml



Benzodiazepines are medications that are frequently prescribed for the symptomatic treatment of anxiety and sleep disorders. They produce their effects via specific receptors involving a neurochemical called gamma aminobutyric acid (GABA). Because they are safer and more effective, Benzodiazepines have replaced barbiturates in the treatment of both anxiety and insomnia. Benzodiazepines are also used as sedatives before some surgical and medical procedures, and for the treatment of seizure disorders and alcohol withdrawal. Risk of physical dependence increases if Benzodiazepines are taken regularly (e.g., daily) for more than a few months, especially at higher than normal doses. Stopping abruptly can bring on such symptoms as trouble sleeping, gastrointestinal upset, feeling unwell, loss of appetite, sweating, trembling, weakness, anxiety and changes in perception. Only trace amounts (less than 1%) of most Benzodiazepines are excreted unaltered in the urine; most of the concentration in urine is conjugated drug. The detection period for Benzodiazepines in urine is 3-7 days. This test yields a positive result when the Benzodiazepines in urine exceeds 300 ng/ml.



5 x 7 in 1 Drug Test Kit

200 in stock

Price: £8.75 exc. VAT

10 x 7 in 1 Drug Test Kit

50 in stock

Price: £18.25 exc. VAT

25 x 7 in 1 Drug Test Kit

50 in stock

Price: £41.50 exc. VAT

50 x 7 in 1 Drug Test Kit

8 in stock

Price: £75.00 exc. VAT

100 x 7 in 1 Drug Test Kit

4 in stock

Price: £145.00 exc. VAT

250 x 7 in 1 Drug Test Kit

3 in stock

Price: £335.00 exc. VAT